• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

3
1
1
1
1

COUNTRY

1
1

CATEGORIES

  • 6
  • 4
  • 2
  • 1
  • 1

PRICE

6
7
7
13

PUBLISHED

1
1
2
13

PRODUCT TYPE

10
2
1

Search "iNova Pharmaceuticals (Australia) Pty Limited-Company Report" returned 13 results.

Impact of Patent Expiration on Key Drugs Categories for 2012-2016 - A Survey Report

TechNavio's analysts have conducted a survey on Impact of Patent Expiration on Key Drugs Categories for 2012-2016. The survey assessed the Impact of Patent Expiration on several key drugs categories...

November 2012
FROM

Respiratory Tract Inflammatory Disorders - Pipeline Review, H2 2012

Respiratory Tract Inflammatory Disorders – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Respiratory Tract Inflammatory Disorders - Pipeline Review, H2 2012', provides an overview of...

November 2012
FROM

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2012

Chronic Obstructive Pulmonary Disease (COPD) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2012', provides an overview...

August 2012
FROM

Bronchitis - Pipeline Review, H2 2012

Bronchitis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Bronchitis - Pipeline Review, H2 2012', provides an overview of the Bronchitis therapeutic pipeline. This report provides information...

August 2012
FROM

Biopharmaceutical Contract Manufacturing Market, 2015 - 2025

Characterized by a rapidly expanding product pipeline and a capital intensive manufacturing business, the biopharmaceutical market is witnessing a growing trend towards contract manufacturing. In addition...

May 2015
FROM

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2012

Chronic Obstructive Pulmonary Disease (COPD) – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2012', provides an overview...

February 2012
FROM

Bronchitis - Pipeline Review, H2 2011

Bronchitis - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Bronchitis - Pipeline Review, H2 2011', provides an overview of the Bronchitis therapeutic pipeline. This report provides information...

September 2011
FROM

Bronchitis - Pipeline Review, H1 2012

Bronchitis – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Bronchitis - Pipeline Review, H1 2012', provides an overview of the Bronchitis therapeutic pipeline. This report provides information...

February 2012
FROM

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2011

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2011', provides an overview...

September 2011
FROM

Asthma Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Asthma Therapeutics in US$ Million The major therapeutic segments analyzed are Inhaled corticosteroids, Short acting beta agonists, Long acting beta agonists,...

October 2006
FROM

Global Corporate Debt Demand Declines To $57 Trillion As Credit Risk Concentrates In China, U.S. Jul 15

Abstract MELBOURNE (Standard & Poor's) July 16, 2015--Global corporate debt demand will peak at an estimated $57 trillion by 2019, a decline of 4% from last year's projection, according to an annual...

July 2015

Credit Trends: Potential Bond Rating Upgrades: Pearl Fishing Among Oysters Sep 03

Abstract More entities appear well placed for potential upgrades compared with four months ago, said a report released today from Standard & Poor's Ratings Services, indicating that the trough in this...

September 2003

Aquaporins, Vol 51. Current Topics in Membranes

Aquaporins summarizes the present knowledge in this expanding field of research, starting with the structural analysis of water channel proteins. Subsequent chapters begin with mammalian aquaporins,...

April 2001
FROM
Loading Indicator

Our Clients

Carrefour S.A. Dow Chemical Co Ltd. Motorola Solutions, Inc. Pfizer, Inc. Activision Publishing, Inc. 3M Company Estée Lauder Companies Inc.